HER2/ErbB2 overexpression drives gliomagenesis through ErbB2 heterodimerization-induced tyrosine autophosphorylation and constitutive activation of proliferative signaling pathways, ultimately promoting uncontrolled cellular proliferation and malignant transformation in glioblastoma (94, 95). The gene discussed is ERBB2; the disease is glioblastoma.